Spectrum and Incidence Trends of AIDS- and Non–AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort
- 1 March 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 30 (3) , 554-563
Abstract
Background: Cancer risk is higher in people living with HIV (PLWH) compared with the general population, and cancers related to age are expected to be most prevalent. Methods: We determined the spectrum and incidence rates of AIDS-defining cancers (ADC) and non–AIDS-defining cancers (NADC) and of lung, Hodgkin lymphoma (HL), head and neck (HNC), colon–rectum, anal, liver, breast, prostate, and urinary bladder cancers between January 2010 and December 2015 in the French Dat'AIDS cohort. Incidence rates were calculated by year and compared using the χ2 test for linear trend. Standardized incidence ratios [SIR (95% confidence interval)] were calculated relative to the French general population. Results: Among 44,642 patients, corresponding to 180,216.4 person-years (PY), 1,440 cancer cases occurred in 1,314 patients. ADC incidence was 191.4 (172.3–212.7)/105 PY and declined over time overall and in men, whereas NADC incidence was higher [548.8 (515.6–584.1)/105 PY] and did not change. In men, non-Hodgkin lymphoma was the most common cancer, but prostate cancer had the highest incidence among NADCs. Breast cancer was the most common cancer in women. SIRs were higher for cervical cancer [1.93 (1.18–3.14)], HNC in women [2.4 (1.4–4.2)], liver [overall: 3.8 (3.1–4.6); men: 3.2 (2.5–4.0); women: 12.9 (8.3–20.0)], and HL [overall: 13.8 (11.1–17.1); men: 16.2 (12.9–20.4); women: 6.2 (3.22–11.9)] but lower for lung [overall: 0.7 (0.6–0.9); men: 0.7 (0.5–0.8)], prostate [0.6 (0.5–0.7)], and breast cancers [0.6 (0.4–0.7)]. Conclusions: Spectrum of NADCs has changed, with prostate and breast cancers becoming the most common despite their lower SIR. Impact: These results confirm the need to maintain regular epidemiologic cancer monitoring in order to update screening guidelines.Keywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
This publication has 42 references indexed in Scilit:
- Epidemiologic contributions to recent cancer trends among HIV-infected people in the United StatesAIDS, 2014
- Risk of AIDS-Defining Cancers Among HIV-1–Infected Patients in France Between 1992 and 2009: Results From the FHDH-ANRS CO4 CohortClinical Infectious Diseases, 2013
- Invasive Cervical Cancer Risk Among HIV-Infected WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapyBlood, 2011
- The spectrum of malignancies in HIV‐infected patients in 2006 in France: The ONCOVIH studyInternational Journal of Cancer, 2011
- Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort StudyBritish Journal of Cancer, 2010
- A Case–Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over TimeJNCI: Journal of the National Cancer Institute, 2009
- HIV infection and the risk of cancers with and without a known infectious causeAIDS, 2009
- Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck CancersJNCI: Journal of the National Cancer Institute, 2008
- Case–Control Study of Human Papillomavirus and Oropharyngeal CancerNew England Journal of Medicine, 2007